tiprankstipranks
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market

OncoArendi Therapeutics SA (MOC) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
OncoArendi Therapeutics SA’s (MOC) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting OncoArendi Therapeutics SA is a Buy.
OncoArendi Therapeutics SA’s (MOC) 20-Day exponential moving average is 5.66, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 50-Day exponential moving average is 5.71, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Sell.

OncoArendi Therapeutics SA (MOC) Pivot Points

Jun 14, 2026, 09:56 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.20
5.26
5.37
5.43
5.54
5.60
5.71
Fibonacci
5.26
5.32
5.37
5.43
5.49
5.54
5.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (MOC) Moving Averages

Jun 14, 2026, 09:56 PM
Period
Simple
Exponential
MA5
5.70Buy
5.67Buy
MA10
5.79Sell
5.69Buy
MA20
5.61Buy
5.66Buy
MA50
5.53Buy
5.71Sell
MA100
6.20Sell
5.99Sell
MA200
6.57Sell
6.32Sell
OncoArendi Therapeutics SA’s (MOC) 10-Day exponential moving average is 5.69, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 100-Day exponential moving average is 5.99, while OncoArendi Therapeutics SA’s (MOC) share price is zł5.2, making it a Sell.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.2 and OncoArendi Therapeutics SA’s (MOC) 50-day simple moving average is 5.53, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.2 and OncoArendi Therapeutics SA’s (MOC) 100-day simple moving average is 6.20, creating a Sell signal.
OncoArendi Therapeutics SA’s (MOC) stock price is zł5.2 and OncoArendi Therapeutics SA’s (MOC) 200-day simple moving average is 6.57, creating a Sell signal.

OncoArendi Therapeutics SA (MOC) Technical Indicators

Jun 14, 2026, 09:56 PM
Name
Value
Implied Action
RSI (14)
51.61
Neutral
STOCH (9,6)
30.03
Neutral
STOCHRSI (14)
31.72
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
25.25
Neutral
Williams %R
-53.12
Buy
CCI (14)
-5.95
Neutral
ATR (14)
0.31
-
Ultimate Oscillator
51.11
Neutral
ROC
5.95
Buy
OncoArendi Therapeutics SA’s (MOC) Relative Strength Index (RSI) is 51.61, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Trend Strength Indicator (ADX) is 25.25, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Commodity Channel Index (CCI) is -5.95, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Price Rate of Change (ROC) is 5.95, creating a Buy signal.

FAQ

Is MOC a Buy, Hold, or Sell?
Based on MOC’s technical indicators, MOC is a Hold.
    What is MOC’s RSI (14)?
    MOC’s RSI (14) is 51.61, which suggests MOC is a Neutral.
      What is MOC’s MACD?
      MOC’s MACD is 0.04, which suggests MOC is a Buy.
        What is MOC’s 5-day moving average?
        MOC’s 5-day moving average is 5.70, which suggests MOC is a Buy.
          What is MOC’s 20-day moving average?
          MOC 20-day moving average is 5.61, which suggests MOC is a Buy.
            What is MOC’s 50-day moving average?
            MOC’s 50-day moving average is 5.53, which suggests MOC is a Buy.
              What is MOC’s 200-day moving average?
              MOC’s 200-day moving average is 6.57, which suggests MOC is a Sell.
                What is MOC’s Williams % R (14)?
                MOC’s Williams % R (14) is -53.12, which suggests MOC is a Buy.
                  What is MOC’s CCI (14)?
                  MOC’s CCI (14) is -5.95, which suggests MOC is a Neutral.
                    What is the share price of OncoArendi Therapeutics SA?